Patent 11957877 was granted and assigned to Dexcom on April, 2024 by the United States Patent and Trademark Office.
Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, a controller module, and optionally a single point glucose monitor are provided. Integration may be manual, semi-automated and/or fully automated.